Massimo Cugno Selected Research

Proteinase-Activated Receptors

1/2019	Coagulation and Skin Autoimmunity.
3/2010	Skin autoimmunity and blood coagulation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Massimo Cugno Research Topics

Disease

17	Inflammation (Inflammations) 05/2023 - 12/2002
15	Chronic Urticaria 04/2023 - 05/2006
13	Angioedema 09/2021 - 08/2002
8	Atypical Hemolytic Uremic Syndrome 01/2024 - 08/2013
8	COVID-19 05/2023 - 01/2021
8	Necrosis 01/2019 - 07/2004
7	Rheumatoid Arthritis 01/2022 - 09/2008
6	Thrombotic Microangiopathies 07/2022 - 08/2013
6	Urticaria (Hives) 09/2021 - 05/2006
5	Thrombosis (Thrombus) 07/2022 - 03/2004
5	Skin Diseases (Skin Disease) 01/2019 - 09/2012
5	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 11/2015 - 11/2007
4	Bullous Pemphigoid (Pemphigoid) 01/2022 - 09/2012
4	Blister (Bulla) 01/2019 - 09/2009
3	Hypersensitivity (Allergy) 12/2021 - 09/2012
3	Edema (Dropsy) 01/2019 - 12/2002
3	Acquired angioedema 09/2013 - 12/2008
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 09/2013 - 12/2008
3	Hereditary Angioedemas 02/2013 - 02/2009
3	Heart Failure 07/2005 - 12/2002
2	Synovitis 01/2022 - 03/2010
2	HELLP Syndrome 12/2020 - 11/2012
2	Infections 03/2020 - 04/2015
2	Autoimmune Diseases (Autoimmune Disease) 01/2019 - 04/2010
2	Pyoderma Gangrenosum 04/2018 - 12/2014
2	Hidradenitis Suppurativa 04/2018 - 12/2014
2	Neoplasms (Cancer) 04/2015 - 05/2014
2	Hemorrhage 01/2014 - 01/2014
2	Paraproteinemias (Monoclonal Gammopathy) 09/2013 - 12/2008
2	Sepsis (Septicemia) 04/2010 - 02/2009
2	Myocardial Infarction 02/2010 - 04/2004
1	Venous Thrombosis (Deep-Vein Thrombosis) 09/2022
1	Severe Acute Respiratory Syndrome 06/2022
1	Wells syndrome 01/2022
1	Atherosclerosis 01/2022
1	Cutaneous Mastocytosis 01/2022
1	Insulin Resistance 01/2022
1	Vasculitis (Vasculitides) 01/2022
1	Erythema Multiforme 01/2022
1	Purpura 01/2022

Drug/Important Bio-Agent (IBA)

20	Complement System Proteins (Complement)IBA 01/2024 - 12/2008
12	AutoantibodiesIBA 01/2023 - 12/2008
12	CytokinesIBA 01/2022 - 12/2002
11	Thrombin FDA Link 12/2019 - 07/2004
9	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 12/2002
9	BradykininIBA 09/2021 - 08/2002
8	Biomarkers (Surrogate Marker)IBA 05/2023 - 07/2004
8	fibrin fragment D (D-dimer)IBA 05/2023 - 07/2004
8	Omalizumab (Xolair)FDA Link 04/2023 - 02/2014
8	AntibodiesIBA 06/2022 - 03/2004
7	C-Reactive ProteinIBA 05/2023 - 04/2004
7	Interleukin-6 (Interleukin 6)IBA 01/2023 - 04/2004
7	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 09/2021 - 10/2002
6	Thromboplastin (Tissue Factor)IBA 12/2018 - 03/2007
5	von Willebrand FactorIBA 05/2023 - 07/2004
5	Immunoglobulin G (IgG)IBA 01/2023 - 03/2020
5	eculizumab FDA Link 01/2022 - 08/2013
5	Peptides (Polypeptides)IBA 09/2021 - 07/2005
5	Histamine Antagonists (Antihistamines)IBA 01/2019 - 03/2003
5	Prothrombin (Factor II)IBA 05/2016 - 05/2006
4	Fibrinogen (Factor I)FDA Link 05/2023 - 07/2004
4	Immunoglobulin E (IgE)IBA 01/2023 - 04/2010
4	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2021 - 10/2002
4	Histamine (Histamine Dihydrochloride)FDA Link 01/2019 - 01/2009
4	InterleukinsIBA 02/2018 - 09/2008
4	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2016 - 03/2004
3	Immunoglobulin A (IgA)IBA 01/2022 - 03/2020
3	Immunoglobulin M (IgM)IBA 01/2022 - 03/2020
3	Antirheumatic Agents (DMARD)IBA 01/2022 - 04/2018
3	AnticoagulantsIBA 01/2019 - 07/2004
3	Complement C1 Inhibitor Protein (C1 Esterase Inhibitor)IBA 01/2013 - 02/2009
3	Plasminogen Activators (Plasminogen Activator)IBA 06/2012 - 07/2004
2	IgE Receptors (Fc epsilon RI)IBA 01/2023 - 04/2010
2	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 09/2022 - 07/2004
2	Complement Factor H (Factor H)IBA 01/2021 - 11/2012
2	EnzymesIBA 12/2020 - 10/2011
2	Peptide Hydrolases (Proteases)FDA Link 01/2019 - 03/2010
2	Proteinase-Activated ReceptorsIBA 01/2019 - 03/2010
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 10/2014
2	Interleukin-17 (Interleukin 17)IBA 02/2018 - 08/2017
2	Interleukin-1 (Interleukin 1)IBA 08/2017 - 12/2002
2	Anti-Bacterial Agents (Antibiotics)IBA 03/2016 - 10/2013
2	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2016 - 01/2015
2	Intravenous Immunoglobulins (IVIG)FDA Link 03/2016 - 01/2014
2	Infliximab (Remicade)FDA Link 11/2015 - 09/2008
2	AntigensIBA 01/2014 - 08/2002
2	Factor VII (Proconvertin)IBA 06/2012 - 07/2004
2	Heparin (Liquaemin)FDA LinkGeneric 01/2010 - 04/2004
2	Factor XIIa (Coagulation Factor XIIa)IBA 07/2005 - 04/2004
2	prothrombin fragment 1IBA 07/2004 - 04/2004
1	HemosiderinIBA 05/2023
1	Ferritins (Ferritin)IBA 05/2023
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2023
1	Interleukin-8 (Interleukin 8)IBA 01/2023
1	Interleukin-10 (Interleukin 10)IBA 01/2023
1	cupric sulfide (CuS)IBA 09/2022
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2022

Therapy/Procedure

12	Therapeutics 12/2021 - 10/2002
2	Glycemic Control 04/2010 - 02/2009
1	Hematopoietic Stem Cell Transplantation 07/2022